In a patient with locally advanced cervical cancer that has extensive residual disease (>7 cm in greatest dimension) after chemoradiation, how do you weigh the geometric advantages of a Syed-Neblett template against the superior toxicity profile and outpatient feasibility of an advanced hybrid applicator? For those who prefer hybrid applicators in this space, what specific techniques or needle configurations do you use to safely cover a tumor of this volume without exceeding OAR limits?